Literature DB >> 26629197

Associated factors of radiation pneumonitis induced by precise radiotherapy in 186 elderly patients with esophageal cancer.

Zhen Cui1, Ye Tian2, Bin He3, Hongwei Li3, Duojie Li3, Jingjing Liu3, Hanfei Cai3, Jianjun Lou3, Hao Jiang3, Xueming Shen3, Kaigui Peng3.   

Abstract

BACKGROUND: Radiation pneumonitis is one of the most severe complications of esophageal cancer.
PURPOSE: To explore the factors correlated to radiation pneumonitis induced by precise radiotherapy for elderly patients with esophageal cancer.
METHODS: The retrospective analysis was used to collect clinical data from 186 elderly patients with esophageal cancer. The incidence of radiation pneumonitis was observed, followed by statistical analysis through ANVON or multiple regression analysis.
RESULTS: 27 in 186 cases of esophageal cancer suffered from radiation pneumonitis, with incidence of 14.52%. The single factor analysis showed that, Karnofsky performance status (KPS) score, chronic obstructive pulmonary disease, concurrent chemoradiotherapy, gross tumor volume (GTV) dose, lung V20, mean lung dose (MLD) and planning target volume (PTV) were associated with radiation pneumonitis. The logistic regression analysis indicated that, concurrent chemoradiotherapy, GTV dose, lung V20 and PTV were the independent factors of radiation pneumonitis.
CONCLUSION: The concurrent chemoradiotherapy, GTV dose, lung V20, MLD and PTV are the major risk factors of radiation pneumonitis for elderly patients with esophageal cancer.

Entities:  

Keywords:  Elderly; esophageal tumor; factors; precise radiotherapy; radiation pneumonitis

Year:  2015        PMID: 26629197      PMCID: PMC4659085     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

1.  Radiotherapy in elderly patients with inoperable esophageal cancer. Is there a benefit?

Authors:  R Semrau; S L Herzog; D Vallböhmer; M Kocher; A Hölscher; R-P Müller
Journal:  Strahlenther Onkol       Date:  2012-02-10       Impact factor: 3.621

2.  Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma.

Authors:  Ze-Tian Shen; Xin-Hu Wu; Bing Li; Jun-Shu Shen; Zhen Wang; Jing Li; Xi-Xu Zhu
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Symptomatic radiation pneumonitis in elderly patients receiving thoracic irradiation.

Authors:  Jordan Kharofa; Elizabeth Gore
Journal:  Clin Lung Cancer       Date:  2013-01-04       Impact factor: 4.785

4.  High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer.

Authors:  Yang-Gun Suh; Ik Jae Lee; Wong Sub Koom; Jihye Cha; Jong Young Lee; Soo Kon Kim; Chang Geol Lee
Journal:  Jpn J Clin Oncol       Date:  2014-04-24       Impact factor: 3.019

5.  A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer.

Authors:  Hyun-Jeong Shim; Dae-Eun Kim; Jun-Eul Hwang; Woo-Kyun Bae; Taek-Keun Nam; Kook-Joo Na; Sang-Hee Cho; Ik-Joo Chung
Journal:  Cancer Chemother Pharmacol       Date:  2012-08-30       Impact factor: 3.333

6.  Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.

Authors:  N Gerber; D H Ilson; A J Wu; Y Y Janjigian; D P Kelsen; J Zheng; Z Zhang; M S Bains; N Rizk; V W Rusch; K A Goodman
Journal:  Dis Esophagus       Date:  2013-06-24       Impact factor: 3.429

7.  Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).

Authors:  Ken Kato; Kei Muro; Keiko Minashi; Atsushi Ohtsu; Satoshi Ishikura; Narikazu Boku; Hiroya Takiuchi; Yoshito Komatsu; Yoshinori Miyata; Haruhiko Fukuda
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-06       Impact factor: 7.038

8.  Postoperative radiotherapy for incompletely resected non-small cell lung cancer: clinical outcomes and prognostic value of the histological subtype.

Authors:  Takayuki Ohguri; Katsuya Yahara; Seung Dae Moon; Shinsaku Yamaguchi; Hajime Imada; Takeshi Hanagiri; Fumihiro Tanaka; Hiromi Terashima; Yukunori Korogi
Journal:  J Radiat Res       Date:  2012-02-13       Impact factor: 2.724

9.  Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival.

Authors:  Alberto Ruol; Giuseppe Portale; Giovanni Zaninotto; Matteo Cagol; Francesco Cavallin; Carlo Castoro; Vanna Chiarion Sileni; Rita Alfieri; Sabrina Rampado; Ermanno Ancona
Journal:  J Thorac Cardiovasc Surg       Date:  2007-05       Impact factor: 5.209

10.  Dose-volume analysis for respiratory toxicity in intrathoracic esophageal cancer patients treated with definitive chemoradiotherapy using extended fields.

Authors:  Satoshi Tanabe; Miyako Myojin; Shinichi Shimizu; Masaharu Fujino; Hiroaki Takahashi; Hiroki Shirato; Yoichi M Ito; Masayori Ishikawa; Masao Hosokawa
Journal:  J Radiat Res       Date:  2013-05-09       Impact factor: 2.724

View more
  10 in total

1.  Beclin 1 expression is associated with the occurrence and development of esophageal squamous cell carcinoma.

Authors:  Hailei Du; Jiamin Che; Minmin Shi; Lianggang Zhu; Jun Biao Hang; Zhongyuan Chen; Hecheng Li
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

2.  Effect of Pingchuan Guben decoction on patients with chronic obstructive pulmonary disease: Results from a randomized comparative effectiveness research trial.

Authors:  Cheng-Liang Qian; Rong Fan
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

3.  Dosimetric comparison and biological evaluation of fixed-jaw intensity-modulated radiation therapy for T-shaped esophageal cancer.

Authors:  Hua Chen; Ying Huang; Hao Wang; Yan Shao; Ning J Yue; Hengle Gu; Yanhua Duan; Aihui Feng; Zhiyong Xu
Journal:  Radiat Oncol       Date:  2021-08-19       Impact factor: 3.481

4.  Modeling the risk of radiation pneumonitis in esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.

Authors:  Kaiqi Lan; Cheng Xu; Shiliang Liu; Jinhan Zhu; Yadi Yang; Li Zhang; Suping Guo; Mian Xi
Journal:  Esophagus       Date:  2021-06-15       Impact factor: 4.230

5.  Relationship Between Radiation Pneumonitis Following Definitive Radiotherapy for Non-small Cell Lung Cancer and Isodose Line.

Authors:  Shigenobu Watanabe; Ichiro Ogino; Daisuke Shigenaga; Masaharu Hata
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  Fixed-jaw technique to improve IMRT plan quality for the treatment of cervical and upper thoracic esophageal cancer.

Authors:  Wei Song; Hong Lu; Jie Liu; Di Zhao; Jun Ma; Biyun Zhang; Dahai Yu; Xinchen Sun; Jinkai Li
Journal:  J Appl Clin Med Phys       Date:  2019-08-28       Impact factor: 2.102

7.  Investigation of Predictors to Achieve Acceptable Lung Dose in T-Shaped Upper and Middle Esophageal Cancer With IMRT and VMAT.

Authors:  Yan Shao; Hua Chen; Hao Wang; Yanhua Duan; Aihui Feng; Ying Huang; Hengle Gu; Qing Kong; Zhiyong Xu
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

Review 8.  Review of clinical results of charged-particle therapy for esophageal cancer.

Authors:  Takashi Ono
Journal:  Esophagus       Date:  2020-07-11       Impact factor: 4.230

9.  Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.

Authors:  Lina Zhao; Yongchun Zhou; Haitao Pan; Yutian Yin; Guangjin Chai; Yunfeng Mu; Feng Xiao; Steven H Lin; Mei Shi
Journal:  J Cancer       Date:  2017-09-15       Impact factor: 4.207

10.  Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Randomized Clinical Trial.

Authors:  Honglei Luo; Wei Jiang; Li Ma; Peng Chen; Min Fang; Lingyu Ding; Yuhui Hua; Dexi Du; Zhao Jing; Ruifei Xie; Yaqi Song; Jiayang Wang; Rongjing Zhou; Zhifeng Tian; Shixiu Wu
Journal:  JAMA Netw Open       Date:  2020-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.